Home NDC 13537-359 CYZONE
Product NDC 13537-359
11-digit product format 135370359
Labeler code 13537
Product ID 13537-359_156122c9-649f-4d7a-b71d-42fe937bf860
Type HUMAN OTC DRUG
Nonproprietary name Aluminum Sesquichlorohydrate
Dosage form LIQUID
Route TOPICAL
Labeler Ventura Corporation (San Juan, P.R)
Application part350
Marketing category OTC MONOGRAPH FINAL
Marketing start 2011-05-27
Marketing end 0000-00-00
Substance ALUMINUM SESQUICHLOROHYDRATE
Active strength 0 mL/mL
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 44 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 13537-359-01 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 13537-359-01 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 13537-359-01 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 13537-359-01 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 13537-359-01 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 13537-359-01 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 13537-359-01 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 13537-359-01 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 13537-359-01 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 13537-359-01 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 13537-359-01 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 13537-359-01 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 13537-359-01 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 13537-359-01 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 13537-359-01 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 13537-359-01 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 13537-359-01 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 13537-359-01 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 13537-359-01 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 13537-359-01 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 13537-359-01 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product I Inactivated by FDA 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 13537-359-01 I Inactivated by FDA 110d247fa046…a55b01930146…
FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded Aluminum Sesquichlorohydrate ACTIVE INGREDIENT UCN889409V CYZONE (ALUMINUM SESQUICHLOROHYDRATE) LIQUID [VENTURA CORPORATION (SAN JUAN, P.R)] 1 Aluminum Sesquichlorohydrate ACTIVE MOIETY UCN889409V CYZONE (ALUMINUM SESQUICHLOROHYDRATE) LIQUID [VENTURA CORPORATION (SAN JUAN, P.R)] 1 BENZALKONIUM CHLORIDE INACTIVE INGREDIENT F5UM2KM3W7 CYZONE (ALUMINUM SESQUICHLOROHYDRATE) LIQUID [VENTURA CORPORATION (SAN JUAN, P.R)] 1 CYCLOMETHICONE 5 INACTIVE INGREDIENT 0THT5PCI0R CYZONE (ALUMINUM SESQUICHLOROHYDRATE) LIQUID [VENTURA CORPORATION (SAN JUAN, P.R)] 1 CYCLOMETHICONE 6 INACTIVE INGREDIENT XHK3U310BA CYZONE (ALUMINUM SESQUICHLOROHYDRATE) LIQUID [VENTURA CORPORATION (SAN JUAN, P.R)] 1 DICAPRYLYL CARBONATE INACTIVE INGREDIENT 609A3V1SUA CYZONE (ALUMINUM SESQUICHLOROHYDRATE) LIQUID [VENTURA CORPORATION (SAN JUAN, P.R)] 1 EDETATE SODIUM INACTIVE INGREDIENT MP1J8420LU CYZONE (ALUMINUM SESQUICHLOROHYDRATE) LIQUID [VENTURA CORPORATION (SAN JUAN, P.R)] 1 LEVOMENOL INACTIVE INGREDIENT 24WE03BX2T CYZONE (ALUMINUM SESQUICHLOROHYDRATE) LIQUID [VENTURA CORPORATION (SAN JUAN, P.R)] 1 MAGNESIUM CHLORIDE INACTIVE INGREDIENT 02F3473H9O CYZONE (ALUMINUM SESQUICHLOROHYDRATE) LIQUID [VENTURA CORPORATION (SAN JUAN, P.R)] 1 MAGNESIUM NITRATE INACTIVE INGREDIENT 77CBG3UN78 CYZONE (ALUMINUM SESQUICHLOROHYDRATE) LIQUID [VENTURA CORPORATION (SAN JUAN, P.R)] 1 METHYLCHLOROISOTHIAZOLINONE INACTIVE INGREDIENT DEL7T5QRPN CYZONE (ALUMINUM SESQUICHLOROHYDRATE) LIQUID [VENTURA CORPORATION (SAN JUAN, P.R)] 1 METHYLISOTHIAZOLINONE INACTIVE INGREDIENT 229D0E1QFA CYZONE (ALUMINUM SESQUICHLOROHYDRATE) LIQUID [VENTURA CORPORATION (SAN JUAN, P.R)] 1 STEARETH-2 INACTIVE INGREDIENT V56DFE46J5 CYZONE (ALUMINUM SESQUICHLOROHYDRATE) LIQUID [VENTURA CORPORATION (SAN JUAN, P.R)] 1 STEARETH-21 INACTIVE INGREDIENT 53J3F32P58 CYZONE (ALUMINUM SESQUICHLOROHYDRATE) LIQUID [VENTURA CORPORATION (SAN JUAN, P.R)] 1 TRICLOSAN INACTIVE INGREDIENT 4NM5039Y5X CYZONE (ALUMINUM SESQUICHLOROHYDRATE) LIQUID [VENTURA CORPORATION (SAN JUAN, P.R)] 1 WATER INACTIVE INGREDIENT 059QF0KO0R CYZONE (ALUMINUM SESQUICHLOROHYDRATE) LIQUID [VENTURA CORPORATION (SAN JUAN, P.R)] 1